Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no...

Solving the mystery of NPM1 in acute myeloid leukaemia

Solving the mystery of NPM1 in acute myeloid leukaemia

Small populations of normal cells affect immunity in patients with XLP1

Small populations of normal cells affect immunity in patients with XLP1

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

Targeted radiation provides option for kids with difficult-to-treat liver cancer

Targeted radiation provides option for kids with difficult-to-treat liver cancer

Researchers have unlocked secrets about engineered protein receptor CAR

Researchers have unlocked secrets about engineered protein receptor CAR

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

First of its kind research models immune responses in cellular immunotherapies

First of its kind research models immune responses in cellular immunotherapies

Gap in research means millions living with long-term consequences of cancer

Gap in research means millions living with long-term consequences of cancer

RNA defects linked to multiple myeloma progression in high risk patients

RNA defects linked to multiple myeloma progression in high risk patients

More from ecancer